Authors: Bernichtein, S Kinet, S Jeay, S Llovera, M Madern, D Martial, JA Kelly, PA Goffin, V

Citation: S. Bernichtein et al., S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist, ENDOCRINOL, 142(9), 2001, pp. 3950-3963

Authors: Llovera, M Pichard, C Bernichtein, S Jeay, S Touraine, P Kelly, PA Goffin, V

Citation: M. Llovera et al., Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation, ONCOGENE, 19(41), 2000, pp. 4695-4705

Authors: Goffin, V Binart, N Clement-Lacroix, P Bouchard, B Bole-Feysot, C Edery, M Lucas, BK Touraine, P Pezet, A Maaskant, R Pichard, C Helloco, C Baran, N Favre, H Bernichtein, S Allamando, A Ormandy, C Kelly, PA

Citation: V. Goffin et al., From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models, GENET A-BIO, 15(3-5), 1999, pp. 189-201

Authors: Goffin, V Touraine, P Pichard, C Bernichtein, S Kelly, PA

Citation: V. Goffin et al., Should prolactin be reconsidered as a therapeutic target in human breast cancer?, MOL C ENDOC, 151(1-2), 1999, pp. 79-87

Authors: Kinet, S Bernichtein, S Kelly, PA Martial, JA Goffin, V

Citation: S. Kinet et al., Biological properties of human prolactin analogs depend not only on globalhormone affinity, but also on the relative affinities of both receptor binding sites, J BIOL CHEM, 274(37), 1999, pp. 26033-26043

Authors: Goffin, V Bernichtein, S Carriere, O Bennett, WF Kopchick, JJ Kelly, PA

Citation: V. Goffin et al., The human growth hormone antagonist B2036 does not interact with the prolactin receptor, ENDOCRINOL, 140(8), 1999, pp. 3853-3856